United States Federal Circuit

In a patent case concerning the prescription drug Lipitor, which is used to reduce certain types of cholesterol levels, a finding of infringement and a ruling that a patent's term extension was not invalid are affirmed, but a ruling on the issue of invalidity is reversed with respect to another patent.

Appellate Information

• Decided 08/02/2006
• Published 08/02/2006

Judges

• MICHEL, Chief Judge., Before MICHEL, Chief Judge, SCHALL and DYK, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellees:
  
• Rudolf E. Hutz, Connolly Bove Lodge & Hutz LLP, of Wilmington, Delaware, argued for plaintiffs-appellees.   With him on the brief were Jeffrey B. Bove, Collins J. Seitz, Jr., Mary W. Bourke, and William E. McShane., William R. Zimmerman, Knobbe, Martens, Olson & Bear, LLP, of Irvine, California, argued for defendants-appellants.   With him on the brief were Darrell L. Olson, John P. Giezentanner, Douglas G. Muehlhauser, and Payson LeMeilleur, of Irvine, California;  and Joseph M. Reisman and Darryl H. Steensma, of San Diego, California.   Of counsel on the brief were Jay R. Deshmukh and George E. Heibel, Ranbaxy, Inc., of Princeton, New Jersey.